Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Aug;109(8):865–869. doi: 10.1289/ehp.01109865

Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects.

A Geusau 1, K Abraham 1, K Geissler 1, M O Sator 1, G Stingl 1, E Tschachler 1
PMCID: PMC1240417  PMID: 11564625

Abstract

A variety of health effects have been attributed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), but little information is available on the course of a verified high-level TCDD intoxication. In this paper we describe two cases of heavy intoxication with TCDD and present a 2-year follow-up including clinical, biochemical, hematologic, endocrine, and immunologic parameters monitored in two women, 30 and 27 years of age, who suffered from chloracne due to TCDD intoxication of unknown origin. Patient 1, who had the highest TCDD level ever recorded in an individual (144,000 pg/g blood fat), developed severe generalized chloracne, whereas in the second patient, despite heavy intoxication (26,000 pg/g blood fat), only mild facial acne lesions occurred. Both patients initially experienced nonspecific gastrointestinal symptoms. In Patient 1 we observed a moderate elevation of blood lipids, leukocytosis, anemia, and secondary amenorrhoea. The laboratory parameters in Patient 2 were all normal. Despite the high TCDD levels, apart from chloracne, only few clinical and biochemical health effects were observed within the first 2 years after TCDD intoxication.

Full Text

The Full Text of this article is available as a PDF (93.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertazzi P. A., Bernucci I., Brambilla G., Consonni D., Pesatori A. C. The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect. 1998 Apr;106 (Suppl 2):625–633. doi: 10.1289/ehp.98106625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Coenraads P. J., Olie K., Tang N. J. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne. Br J Dermatol. 1999 Oct;141(4):694–697. doi: 10.1046/j.1365-2133.1999.03109.x. [DOI] [PubMed] [Google Scholar]
  3. Gao X., Petroff B. K., Rozman K. K., Terranova P. F. Gonadotropin-releasing hormone (GnRH) partially reverses the inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on ovulation in the immature gonadotropin-treated rat. Toxicology. 2000 May 19;147(1):15–22. doi: 10.1016/s0300-483x(00)00161-x. [DOI] [PubMed] [Google Scholar]
  4. Geusau A., Jurecka W., Nahavandi H., Schmidt J. B., Stingl G., Tschachler E. Punctate keratoderma-like lesions on the palms and soles in a patient with chloracne: a new clinical manifestation of dioxin intoxication? Br J Dermatol. 2000 Nov;143(5):1067–1071. doi: 10.1046/j.1365-2133.2000.03846.x. [DOI] [PubMed] [Google Scholar]
  5. Geusau A., Tschachler E., Meixner M., Sandermann S., Päpke O., Wolf C., Valic E., Stingl G., McLachlan M. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Lancet. 1999 Oct 9;354(9186):1266–1267. doi: 10.1016/S0140-6736(99)04271-3. [DOI] [PubMed] [Google Scholar]
  6. Holsapple M. P., Snyder N. K., Wood S. C., Morris D. L. A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology. 1991;69(3):219–255. doi: 10.1016/0300-483x(91)90184-3. [DOI] [PubMed] [Google Scholar]
  7. Kaiser J. Toxicology. Just how bad is dioxin? Science. 2000 Jun 16;288(5473):1941–1944. doi: 10.1126/science.288.5473.1941b. [DOI] [PubMed] [Google Scholar]
  8. König M. P., Kopp P. Hyperprolactinämien. Schweiz Med Wochenschr. 1986 Mar 1;116(9):265–270. [PubMed] [Google Scholar]
  9. Mauri M. C., Bravin S., Bitetto A., Rudelli R., Invernizzi G. A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Saf. 1996 May;14(5):288–298. doi: 10.2165/00002018-199614050-00003. [DOI] [PubMed] [Google Scholar]
  10. Mocarelli P., Marocchi A., Brambilla P., Gerthoux P., Young D. S., Mantel N. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA. 1986 Nov 21;256(19):2687–2695. [PubMed] [Google Scholar]
  11. Morán F. M., Conley A. J., Corbin C. J., Enan E., VandeVoort C., Overstreet J. W., Lasley B. L. 2,3,7,8-tetrachlorodibenzo-p-dioxin decreases estradiol production without altering the enzyme activity of cytochrome P450 aromatase of human luteinized granulosa cells in vitro. Biol Reprod. 2000 Apr;62(4):1102–1108. doi: 10.1095/biolreprod62.4.1102. [DOI] [PubMed] [Google Scholar]
  12. Needham L. L., Gerthoux P. M., Patterson D. G., Jr, Brambilla P., Turner W. E., Beretta C., Pirkle J. L., Colombo L., Sampson E. J., Tramacere P. L. Serum dioxin levels in Seveso, Italy, population in 1976. Teratog Carcinog Mutagen. 1997;17(4-5):225–240. [PubMed] [Google Scholar]
  13. Neubert D. Reflections on the assessment of the toxicity of "dioxins" for humans, using data from experimental and epidemiological studies. Teratog Carcinog Mutagen. 1997;17(4-5):157–215. [PubMed] [Google Scholar]
  14. Ott M. G., Messerer P., Zober A. Assessment of past occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using blood lipid analyses. Int Arch Occup Environ Health. 1993;65(1):1–8. doi: 10.1007/BF00586050. [DOI] [PubMed] [Google Scholar]
  15. Ott M. G., Zober A., Germann C. Laboratory results for selected target organs in 138 individuals occupationally exposed to TCDD. Chemosphere. 1994 Nov-Dec;29(9-11):2423–2437. doi: 10.1016/0045-6535(94)90411-1. [DOI] [PubMed] [Google Scholar]
  16. Schwetz B. A., Norris J. M., Sparschu G. L., Rowe U. K., Gehring P. J., Emerson J. L., Gerbig C. G. Toxicology of chlorinated dibenzo-p-dioxins. Environ Health Perspect. 1973 Sep;5:87–99. doi: 10.1289/ehp.730587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spink D. C., Lincoln D. W., 2nd, Dickerman H. W., Gierthy J. F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an extensive alteration of 17 beta-estradiol metabolism in MCF-7 breast tumor cells. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6917–6921. doi: 10.1073/pnas.87.17.6917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Suskind R. R. Chloracne, "the hallmark of dioxin intoxication". Scand J Work Environ Health. 1985 Jun;11(3 Spec No):165–171. doi: 10.5271/sjweh.2240. [DOI] [PubMed] [Google Scholar]
  19. Sweeney M. H., Calvert G. M., Egeland G. A., Fingerhut M. A., Halperin W. E., Piacitelli L. A. Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen. 1997;17(4-5):241–247. [PubMed] [Google Scholar]
  20. Van den Berg M., De Jongh J., Poiger H., Olson J. R. The toxicokinetics and metabolism of polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) and their relevance for toxicity. Crit Rev Toxicol. 1994;24(1):1–74. doi: 10.3109/10408449409017919. [DOI] [PubMed] [Google Scholar]
  21. Zober A., Ott M. G., Messerer P. Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med. 1994 Jul;51(7):479–486. doi: 10.1136/oem.51.7.479. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES